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Hereditary forms of cataract constitute a clinically 
and genetically heterogeneous disorder of the ocular lens 
(OMIM). They are usually diagnosed at birth (congenital), 
during infancy, or during childhood into adolescence, and 
despite surgical treatment, are an important risk factor for 
lifelong visual impairment [1-3]. In addition to being asso-
ciated with many genetic syndromes and metabolic disor-
ders involving other ocular and/or systemic abnormalities 
(OMIM), cataract may be inherited as an isolated or primary 
lens phenotype, often with autosomal dominant transmission 
and high penetrance [4-6]. Currently, mutations in at least 
22 genes have been linked with autosomal dominant and 
recessive forms of primary cataract that variably affect all 
or specific regions of the lens (e.g., nuclear, lamellar, sutural, 
polar) and exhibit wide variation in size, shape, density, and 
color of opacity, making accurate phenotype-genotype corre-
lations challenging [7]. The majority of underlying mutations 
have been detected in 12 genes encoding alpha-, beta- and 
gamma-crystallins, and connexins alpha-3 and alpha-8, with 
the remainder of mutations found in a functionally diverse 
group of genes including those for an aquaporin, a heat-
shock transcription factor, and intermediate filament-like 
proteins [4-6]. Interestingly, there is increasing evidence that 
variations in several of the genes underlying rare Mendelian 
forms of cataract are also associated with much more frequent 
forms of age-related cataract [6]. For example, coding and 
noncoding variations in the genes for galactokinase defi-
ciency (GALK1) and an ephrin receptor (EPHA2) have been 
associated with age-related cataract in divergent populations 
[8-12] providing new insights into the genetic complexity 
of this universally important cause of low vision and blind-
ness. Here, we have mapped autosomal dominant cataract 
segregating in a Caucasian-American family to chromosome 
19q, identified a recurrent mutation in the iron response 
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Noncoding variation of the gene for ferritin light chain in 
hereditary and age-related cataract
Thomas M. Bennett,1 Giovanni Maraini,2 Chongfei Jin,3 Wenmin Sun,3 J. Fielding Hejtmancik,3 Alan Shiels1
1Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO; 2Department of 
Ophthalmology, University of Parma, Parma, Italy; 3Ophthalmic Genetics and Visual Function Branch, National Eye Institute, 
National Institutes of Health, Bethesda, MD
Purpose: Cataract is a clinically and genetically heterogeneous disorder of the ocular lens and an important cause of 
visual impairment. The aim of this study was to map and identify the gene underlying autosomal dominant cataract 
segregating in a four-generation family, determine the lens expression profile of the identified gene, and test for its as-
sociation with age-related cataract in a case-control cohort.
Methods: Genomic DNA was prepared from blood leukocytes, and genotyping was performed by means of single-
nucleotide polymorphism markers and microsatellite markers. Linkage analyses were performed using the GeneHunter 
and MLINK programs, and mutation detection was achieved by dideoxy cycle sequencing. Lens expression studies were 
performed using reverse-transcription polymerase chain reaction (RT–PCR) and in situ hybridization.
Results: Genome-wide linkage analysis with single nucleotide polymorphism markers in the family identified a likely 
disease-haplotype interval on chromosome 19q (rs888861-[~17Mb]-rs8111640) that encompassed the microsatellite 
marker D19S879 (logarithm of the odds score [Z]=2.03, recombination distance [θ]=0). Mutation profiling of position-
al-candidate genes detected a heterozygous, noncoding G-to-T transversion (c.-168G>T) located in the iron response 
element (IRE) of the gene coding for ferritin light chain (FTL) that cosegregated with cataract in the family. Serum 
ferritin levels were found to be abnormally elevated (~fourfold), without evidence of iron overload, in an affected family 
member; this was consistent with a diagnosis of hereditary hyperferritinemia-cataract syndrome. No sequence varia-
tions located within the IRE were detected in a cohort of 197 cases with age-related cataract and 102 controls with clear 
lenses. Expression studies of human FTL, and its mouse counterpart FTL1, in the lens detected RT–PCR amplicons 
containing full-length protein-coding regions, and strong in situ localization of FTL1 transcripts to the lens equatorial 
epithelium and peripheral cortex.
Conclusions: The data are consistent with robust transcription of FTL in the lens, and suggest that whereas variations 
clustered in the IRE of the FTL gene are directly associated with hereditary hyperferritinemia-cataract syndrome, such 
IRE variations are unlikely to play a significant role in the genetic etiology of age-related cataract.
Correspondence to: Alan Shiels, Ophthalmology and Visual 
Sciences, Box 8096 Washington University School of Medicine 660 
S. Euclid Ave., St. Louis, MO 63110; Phone: (314) 362-1637 FAX: 
(314) 362-1642; email: shiels@vision.wustl.edu
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element (IRE) of the gene for ferritin light chain or L-ferritin 
(FTL), localized expression of FTL in the lens, and evaluated 
sequence variation of the FTL-IRE region in a case-control 
cohort of age-related cataract.
METHODS
Family participants: A four-generation Caucasian-American 
pedigree from the Midwestern United States was ascertained 
through ophthalmic records in the Department of Ophthal-
mology and Visual Sciences at Washington University 
School of Medicine. Blood samples were obtained from 13 
family members, including six affected, four unaffected, and 
three spouses. Leukocyte genomic DNA was purified using 
the Gentra Puregene Blood kit (Qiagen, Valencia, CA), and 
quantified by absorbance at 260 nm (NanoDrop 2000, Wilm-
ington, DE). Ethical approval for this study was obtained 
from the Washington University Human Research Protection 
Office, and written informed consent was provided by all 
participants before enrollment in accordance with the tenets 
of the Declaration of Helsinki, as well as Health Insurance 
Portability and Accountability Act regulations.
Case-control participants: A case-control cohort of unrelated 
individuals aged >55 years from Northern Italy was ascer-
tained from the Clinical Trial of Nutritional Supplements 
and Age-Related Cataract Study [13]. Genomic DNA was 
purified from blood samples using a standardized protocol 
that included detergent lysis of cells and high salt precipita-
tion of proteins followed by ethanol precipitation and phenol/
chloroform extraction of DNA as described [14]. Cataract 
status (nuclear, cortical, posterior subcapsular, clear lens) 
was evaluated by grading slit-lamp and retroillumination lens 
photographs according to a modification of the Age-Related 
Eye Disease Study cataract grading system as described [15]. 
Briefly, a lens was defined as clinically cataractous when 
at least one type of opacity was present with the following 
grades: nuclear opalescence >4.5 (range 0.9-8.1); cortical 
opacity >25% inside the 5 mm diameter circle at the center 
of the pupil and/or >25% outside the central 5 mm diameter 
circle; posterior sub-capsular opacity >12.5% inside the 
central 5 mm diameter circle. A clear lens was defined by 
the following grades: nuclear opalescence <3.0; cortical 
opacity <5% within the central 5 mm diameter circle, and 
<15% outside the central 5 mm diameter circle; posterior sub-
capsular opacity <1.0% within the central 5 mm diameter 
circle. Ethical approval for this study was obtained from 
the University of Parma and the National Eye Institute, and 
written informed consent was provided in accordance with 
the tenets of the Declaration of Helsinki.
Linkage analysis: For genome-wide linkage analysis, single-
nucleotide polymorphism (SNP) genotyping was performed 
by means of the GeneChip Human Mapping 10 K Array Xba 
142 2.0 (Affymetrix, Santa Clara, CA), in the GeneChip Core 
Facility at Washington University Siteman Cancer Center. 
Parametric multipoint linkage analysis was performed using 
an autosomal dominant model with GeneHunter Plus from the 
easyLINKAGE Plus (v. 5.08) package [16]. SNP marker allele 
frequencies used for linkage analysis were those calculated 
for Caucasians by the HapMap project. A frequency of 0.0001 
and a penetrance of 100% were assumed for the disease 
allele. Computation was performed with GeneHunter Plus 
(v.1.2) in sets of 100 markers using the AFFY 10 K deCODE 
human genetic marker map. Confirmation of linkage was 
achieved by genotyping microsatellite markers from the 
NCBI combined Généthon, Marshfield, and deCODE genetic 
linkage maps, as described [17]. Pedigree and haplotype data 
were managed using Cyrillic (v. 2.1) software (FamilyGen-
etix Ltd., Reading, UK), and two-point logarithm of the odds 
(LOD) scores (Z) calculated using the MLINK sub-program 
from the LINKAGE (5.1) package of programs [18]. Marker 
allele frequencies were assumed to be equal, and a frequency 
of 0.0001 with a penetrance of 100% was assumed for the 
disease allele.
Sequencing: Genomic sequence for lens intrinsic membrane 
protein-2 (Gene ID: 3982) and FTL (Gene ID: 2512) were 
obtained from the Ensembl human genome browser, and 
gene-specific M13-tailed PCR primers (Table 1) were 
selected from the NCBI resequencing amplicon probe data-
base or custom designed with Primer Quest (IDT.com) or 
Exon Primer (UCSC Genome Bioinformatics). Exons were 
PCR amplified then cycle-sequenced in both directions 
using BigDye Terminator Mix (v3.1) and a 3130×l-16 Genetic 
Analyzer (Applied Biosystems, Foster City, CA), as described 
[9].
Serum ferritin and plasma iron profile: Fasting blood samples 
were collected by venipuncture into either anticoagulant-free 
tubes for serum, or lithium heparin tubes for plasma (BD, 
Franklin Lakes, NJ). Serum ferritin was measured by means 
of chemiluminescence enzyme immunoassay (ADVIA 
Centaur; Bayer, Pittsburg, PA). Plasma iron profile, including 
iron, iron-binding capacity, and transferrin saturation, was 
determined by colorimetric (Ferrochrome/Ferrozine) assay 
(Roche Diagnostics, Indianapolis, IN). Transferrin saturation 
(%) was calculated from iron concentration divided by total 
iron binding capacity. Assays were conducted according to 
Clinical Laboratory Improvement Amendments regulations 
at Barnes-Jewish Hospital Laboratory.
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Eye tissue collection and preparation: Mice (C57B6/J, post-
natal day 21-28) were humanely killed by CO2 asphyxiation 
followed by cervical dislocation. Eyes were removed and 
fixed in 10% neutral buffered formalin (Fisher Scientific, Fair 
Lawn, NJ) for 24 h at 20 °C before histology using standard 
formaldehyde-fixed-paraffin-embedded (FFPE) techniques. 
Alternatively, mouse eyes were placed in pre-warmed (37°C) 
phosphate buffered saline (PBS; 10 mM phosphate buffer, 2.7 
mM potassium chloride, 137 mM sodium chloride, pH 7.4) 
and lenses dissected through a posterior incision in the globe 
then stored (−20 °C) in RNAlater (Invitrogen, Carlsbad, CA). 
Postmortem human lenses were obtained (frozen on dry ice) 
from the Lions Eye Bank of Oregon. All tissue procurement 
procedures were approved by the Washington University 
Human Research Protection Office and Animal Studies 
Committee, and conformed to the guidelines published by 
the Institute for Laboratory Animal Research.
Reverse-transcription polymerase chain reaction: Total 
cellular RNA was extracted from mouse and human lenses 
by means of the RNeasy Plus Micro kit (Qiagen) and TRIzol 
reagent (Invitrogen), respectively, then quantified by ultra-
violet absorbance (ND2000, Nanodrop). Lens RNA (250 ng) 
was reverse transcribed in the presence of random hexamers 
with the iScript cDNA synthesis kit (Bio-Rad, Hercules, 
CA), and cDNA products amplified (GeneAmp 9700 thermal 
cycler, Applied Biosystems) with gene-specific primers 
(Table 1) using Top-Taq reagents (Qiagen) according to the 
manufacturer’s instructions. Reverse-transcription poly-
merase chain reaction (RT–PCR) amplicons were visualized 
(302 nm) by electrophoresis on 2% agarose-gels stained with 
GelRed (Biotium, Hayward, CA). Amplicon identity was 
confirmed by sequencing as described above.
In situ hybridization: In situ hybridization (ISH) was 
performed using the RNAscope 2.0 FFPE Reagent Kit - 
RED (Advanced Cell Diagnostics, Inc. Hayward, CA) with 
custom synthesized target probes designed for the mouse 
FTL1 transcript (NM_010240.2, 986 bp mRNA), essen-
tially as described [19]. The target probe region (6–908 bp) 
Table 1. PCR PRimeRs used foR amPlifiCaTion of human fTl and lim2, and mouse fTl1.
Primer Location Strand Sequence (5′ - 3′)
FTL-IREF 5′-UTR sense ATTTCACAACACGCTGGCGCTACA
FTL-Ex1R Intron-1 antisense TCTGTTTACCCGACCGCACAAAGA
32G>TR IRE antisense GTTCCGTCCAAACACTGTTGAAGA
FTL-Ex2F Intron-1 sense GAGTCCCCTTGGCCTCG
FTL-Ex2R Intron-2 antisense GACACCTACGCCCTCAAATC
FTL-Ex3F Intron-2 sense CCAACGACTCTTGGGAAATG
FTL-Ex3R Intron-3 antisense AAAGGGAGCAGAGGCTTGAG
FTL-Ex4F Intron-3 sense TCAGAGCCTCATTTCACACC
FTL-Ex4R Exon-4 antisense CCAACTCCTCTTTCACTGGC
FTL-Start Exon-1 sense ATGAGCTCCCAGATTCGTCAG
FTL-Stop Exon-4 antisense TTAGTCGTGCTTGAGAGTGAG
FTL1-Start Exon-1 sense ATGACCTCTCAGATTCGTCAG
FTL1-Stop Exon-4 antisense CTAGTCGTGCTTGAGAGTGAG
LIM2-Ex1F Exon-1 sense GGACTTCCAGGTTCTGAGCAAGG
LIM2-Ex1R Intron-1 antisense CGGACAAAGCCAGGGTTGCT
LIM2-Ex2F Intron-1 sense TGTGCATGACACCTCTGAAGCG
LIM2-Ex2R Intron-2 antisense GCATCCCACTCCTGAGCCCT
LIM2-Ex3F Intron-2 sense GCTGAGGTGGAAGCAGTCTTGC
LIM2-Ex3R Intron-3 antisense TTGCCAGGTGAAGAAGAGGGC
LIM2-Ex4F Intron-3 sense CCCAACACCCTACTCTCTTTCTCCC
LIM2-Ex4R Intron-4 antisense CCAAATATTGTTTCTCCCTCCCAGG
LIM2-Ex5F Intron-4 sense CCACCCTTACAGCTGTTTCTCCC
LIM2-Ex5R Exon-5 antisense CCCACATGAGTCCCACAGCA
Gene-specific primer-pairs used for amplification and sequencing of exons or transcripts.
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covered 5′-untranslated region (5′-UTR; 6–255 bp), coding 
sequence (256–807 bp), and 3′-UTR (808–908 bp). Briefly, 
FFPE microtome sections (5 µm, RM2255, Leica Microsys-
tems, Buffalo Grove, IL) on glass slides (SuperFrost Plus) 
were baked (1 h, 60 °C), dewaxed in xylene, dehydrated in 
ethanol, boiled in citrate buffer, then protease treated (10 ug/
ml) in a HybEZ Oven (40 °C, 30 min). Pretreated sections 
were hybridized with target probes (2 h, 40 °C), followed 
by signal amplification oligonucleotides (15–30 min, 40 °C), 
then alkaline phosphatase–conjugated Fast-Red label probe 
(15–30 min, 20 °C). Labeled sections were treated with chro-
mogenic Fast-Red substrate (10 min, 20 °C), counterstained 
(Gill’s Hematoxylin-1/0.01% ammonia-H2O), mounted 
(Clear-Mount), and imaged under a bright-field microscope 
(Olympus, BX51) fitted with a digital camera (Spot RT3).
RESULTS
Linkage analysis: We studied a four-generation Caucasian 
pedigree from the Midwestern United States, segregating 
star-shaped opacities affecting the lens nucleus and cortex 
(Figure 1). Autosomal dominant inheritance was supported 
by father-to-son transmission in the absence of generation 
skipping. Ophthalmic records indicated that the cataract was 
bilateral in the absence of other obvious ocular or systemic 
abnormalities. Age at diagnosis varied from 0.5 to 25 years, 
and age at surgery varied from 15 to 63 years. Postsurgical 
corrected visual acuity varied from 20/20 to 20/30 in the 
better eye.
For genome-wide linkage analysis, the six affected and 
seven unaffected family members were genotyped by means 
of the GeneChip Mapping 10 K 2.0 Array, which comprises 
10,204 SNP markers uniformly spaced at a mean intermarker 
distance of 258 kb, with an average heterozygosity of 0.38. 
Parametric multipoint analysis detected suggestive evidence 
of a linkage between SNP markers rs1366444 and rs2241721 
(parametric LOD score 2.37) on chromosome 19q (Figure 2). 
Haplotype reconstruction detected two obligate recombinant 
individuals in the pedigree who defined a common disease 
interval that cosegregated with cataract in all six affected 
individuals (Figure 1A and Table 2). An unaffected female 
(III:5) was recombinant at rs888861, and an affected female 
(IV:3) was recombinant at rs8111640. However, no further 
recombinant individuals were detected at other intervening 
markers, consistent with the cataract locus residing in the 
physical interval, rs888861-(~17 Mb)-rs8111640 (chr19: 
35,381,852 - 52,621,644; Figure 1C). To further validate the 
SNP haplotype on 19q, all 13 family members were regeno-
typed with microsatellite markers in the region. We obtained 
confirmatory evidence of linkage at marker D19S879 
(Zmax=2.03, θmax=0), which lies within the SNP interval (Table 
2).
Mutation analysis: The disease interval contained over 840 
positional candidate genes (NCBI Map Viewer), two of 
Figure 1. Linkage analysis of 
autosomal dominant cataract found 
to segregate in a four-generation 
Caucasian-American pedigree. A: 
Pedigree and haplotype analysis 
shows segregation of SNP and 
microsatellite markers on chromo-
some 19q, listed in descending 
order from the centromere (19p-
tel). Squares and circles symbolize 
males and females, respectively. 
Filled symbols and bars denote 
affected status and haplotypes, 
respectively. B: Slit-lamp retroil-
lumination image of a lens from 
individual IV:3 before surgery at ~3 
months of age reveals stellate opaci-
ties that appear as paler regions of 
light scattering against the retinal red reflex. C: Ideogram of chromosome 19 indicates the location of the cataract locus (shaded gray) and 
two positional candidate genes.
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which have been associated with inherited forms of cataract. 
Sequencing of exons and intron boundaries first excluded 
the presence of coding or splice-site mutations in the gene 
for lens intrinsic membrane protein-2, which has been linked 
with autosomal recessive cataract [20,21]. However, we 
detected a heterozygous G-to-T transversion in exon-1 of the 
gene for FTL that was not present in the wild type (Figure 
3). The change (c.-168G>T) was located in the 5′-UTR at 
nucleotide 168 upstream from the A (numbered +1) of the 
translation start-site (ATG), and within the IRE at nucleo-
tide 32 numbered from the consensus transcription start-
site (32G>T). Allele-specific PCR analysis confirmed that 
the T-allele cosegregated with affected, but not unaffected 
family members (Figure 3C). Further, when we tested the 
c.-168G>T transversion as a biallelic marker with a notional 
allelic frequency of 1% in a two-point LOD score analysis of 
the cataract locus (Table 2), we obtained further evidence of 
linkage (Zmax=2.01, θmax=0). In addition, we confirmed that 
the c.-168G>T transversion was not listed in the NCBI SNP 
database (dbSNP), and excluded it as an SNP in a panel of 192 
normal unrelated individuals (i.e., 384 chromosomes) using 
the allele-specific PCR analysis described in Figure 3C (data 
not shown). While it is possible that an undetected mutation 
lay elsewhere within the disease-haplotype interval, our 
genotype data strongly suggested that the c.-168G>T trans-
version in exon-1 of FTL represented a causative mutation 
rather than a benign SNP in linkage disequilibrium with the 
cataract phenotype.
Serum ferritin and iron status: To gain a better differential 
diagnosis for autosomal dominant cataract cosegregating with 
an FTL-IRE mutation, we undertook Clinical Laboratory 
Improvement Amendments–certified testing of serum ferritin 
Figure 2. Parametric multipoint 
logarithm of the odds (pLOD MPT) 
scores were calculated for linkage 
between the cataract phenotype and 
single nucleotide polymorphism 
(SNP) markers across the genome. 
Chromosome length is shown in 
centi-Morgans (cM).
Table 2. Two-PoinT logaRiThm of The odds sCoRes (Z) weRe CalCulaTed foR linkage 
beTween The CaTaRaCT loCus and maRkeRs on ChRomosome 19q.
Marker (recombinant) Mb
Z at recombination fraction (Θ)=
0.00 0.05 0.10 0.20 0.30 0.40 ZMax ΘMax
rs888861 (III:5) 35.38 -∞ −0.64 −0.38 −0.16 −0.06 −0.01 0.00 0.50
D19S220 38.43 1.66 1.51 1.35 1.01 0.66 0.30 1.66 0.00
rs9304618 43.47 1.77 1.63 1.49 1.15 0.77 0.37 1.77 0.00
D19S412 47.01 1.18 1.11 1.02 0.83 0.60 0.32 1.18 0.00
FTL-IRE c.-168G>T 49.47 2.01 1.82 1.62 1.22 0.80 0.38 2.01 0.00
D19S879 49.52 2.03 1.85 1.67 1.27 0.84 0.40 2.03 0.00
rs10500307 52.07 1.91 1.73 1.55 1.17 0.77 0.37 1.91 0.00
rs8111640 (IV:3) 52.62 -∞ −0.39 −0.15 0.04 0.08 0.06 0.08 0.31
D19S571 (IV:3) 53.30 -∞ 0.79 0.91 0.82 0.57 0.25 0.91 0.11
Z values for markers on 19q are listed in physical order measured in mega base pairs (Mb) from the short-arm telomere (19ptel).
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and iron profile in one available, affected family member 
(III:4). She was found to have an abnormally high serum 
ferritin level of 1208 µg/l (expected range 10–291 µg/l). 
However, her serum iron level of 66 µg/dl (range 30–160 µg/
dl), total iron binding capacity value of 293 µg/dl (range 
220–420 µg/dl), and calculated transferrin saturation value 
of 23% (range 20%–50%) were all well within the normal 
adult female range, and were consistent with a diagnosis of 
hereditary hyperferritinemia-cataract syndrome (HHCS, 
OMIM ID: 134790). The absence of an abnormal iron profile 
formally excluded the possibility of classical hereditary 
hemochromatosis, an autosomal recessive inborn error of 
iron metabolism characterized by elevated serum ferritin 
levels, transferrin saturation values >50%, iron overload, 
and variations in the hemochromatosis (HFE) gene linked to 
chromosome 6p [OMIM ID: 235200]. Moreover, four other 
genetic forms of hemochromatosis (HFE2A, HFE2B, HFE3, 
HFE4) were excluded, since they are associated with iron 
overload linked to genes other than FTL (OMIM ID: 608374, 
606464, 604720, 604653).
Iron response element variants in age-related cataract 
case controls: To investigate the possibility that sequence 
variations in the FTL-IRE region are associated with age-
related cataract, we performed amplicon resequencing in 197 
cases with age-related cataract and 102 age/gender-matched 
controls with clear lenses. While no sequence variations in 
the IRE of cases and controls were found (data not shown), 
we detected a heterozygous G-to-A transition (c.-346G>A) 
located upstream of the transcription start site in one case 
with age-related cortical cataract (Appendix 1). However, 
the serum ferritin levels and iron status of this individual 
were unknown. Similarly, a heterozygous C>A transversion 
located 216 nucleotides upstream of the IRE transcription 
start site has been reported in a cataract patient of uncertain 
ferritin and iron status [22]. In addition, at least 19 other vari-
ants in the immediate 5′-UTR of the FTL gene (Appendix 1) 
have been documented in dbSNP, one of which (rs11553230) 
is located within the IRE (c.-174T>C, 26T>C). However, their 
clinical significance is not known.
Human ferritin light chain and mouse ferritin light chain-1 
transcripts in the lens: To determine the expression profile 
of human FTL and its mouse counterpart, FTL1, in the lens 
we undertook RT–PCR amplification and ISH analyses. RT–
PCR confirmed that the full-length coding regions for human 
FTL (codons 1–175 + stop) and mouse FTL1 (codons 1–183 
+ stop) could be amplified from human and mouse lenses, 
respectively (Figure 4D). ISH revealed that FTL1 messenger 
RNA (mRNA) transcripts are most strongly expressed in the 
equatorial epithelium and peripheral cortical fiber cells of 
the young (postnatal day 21) mouse lens, with much lower 
levels detected in other eye tissues (Figure 4). This preferred 
expression profile of the lens is consistent with FTL1 tran-
script levels detected by microarray analysis of mouse eye 
tissues [23].
DISCUSSION
In this study, we have identified a Caucasian-American 
family segregating HHCS. Since it was first described in 
1995 [24-27], HHCS has been reported in over 70 families 
or individuals mostly of European descent, with a minimum 
estimated prevalence of 1/200,000 [28]. Mutations under-
lying HHCS are all clustered in the IRE of the FTL gene 
(Appendix 1 and Appendix 2). This motif comprises approxi-
mately 75 nucleotides of the 5′-UTR, that when transcribed 
Figure 3. Mutation analysis was performed on the ferritin light 
chain – iron response element sequence. A: Sequence trace of the 
wild-type allele shows G at nucleotide 168 upstream from the ATG 
(c.-168G). B: Sequence trace of the mutant allele shows the hetero-
zygous c.-168G>T transversion (denoted K by the International 
Union of Pure and Applied Chemistry code). C: Allele-specific 
PCR analysis using the three primers (Table 1) indicated by arrows 
in the schematic diagram, reveals that the mutant T-allele (277 bp) 
co-segregates with affected but not unaffected family members.
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into mRNA, folds into a hairpin-like secondary structure 
with a characteristic hexanucleotide loop joining the 5′- and 
3′-stem regions generated by Watson–Crick base pairing 
[29,30]. The FTL-IRE mutation spectrum comprises at least 
34 heterozygous mutations, including 27 single nucleotide or 
point changes, two compound heterozygous changes, and five 
deletions ranging from 2 to 29 bp (Appendix 1 and Appendix 
2). The most prevalent mutations occur in the 5′-stem and 
hexanucleotide loop regions. The c.-168G>T (32G>T) change 
described here is located in the 5′-stem region, adjacent to 
the unpaired cytosine “bulge” (c.-167C, 33C), and recurrent 
variations at this site have been reported in at least 17 other 
families of European ancestry and one of Indian descent, 
making it one of the most prevalent mutation sites in the IRE 
[28,31-36]. Outside of the IRE, rare mutations in the coding 
region of FTL have been associated with either neuroferriti-
nopathy or hyperglycosylated serum ferritin associated with 
benign hyperferritinemia in the absence of cataract [37-40].
HHCS has been shown to result from disruption of the 
iron-dependent translational control of FTL gene expression. 
Specifically, HHCS mutations have been shown to alter the 
secondary structure and thermodynamic stability of the 
FTL-IRE stem-loop structure, and to reduce its binding 
affinity for cytoplasmic iron regulatory proteins (IRP1, IRP2) 
that actively repress FTL translation [29,41,42]. Notably, 
molecular modeling predicts that the FTL-IRE mutation 
found here disrupts base-pairing between c.-168G (32G) 
in the 5′-stem and c.-150C (50C) in the 3′-stem, inducing 
altered base pairing within the upper stem and hexaloop 
regions [32]. Further, protein binding assays have confirmed 
that the same c.-168G>T mutation significantly reduced IRP 
binding affinity in vitro [29,31]. Such mutation-induced 
loss of IRE-IRP interaction is expected to result in elevated 
levels of FTL biosynthesis, and large crystalline deposits of 
immunoreactive L-ferritin have been observed in lens tissue 
recovered from HHCS patients following cataract surgery 
[32,42,43]. Our expression data show that FTL transcription 
is higher in the lens compared with other eye tissues (Figure 
4), and further support the concept that even in the presence 
of a wild-type FTL-IRE allele, a mutant FTL-IRE allele 
causes autosomal dominant cataract through uncontrolled 
(derepressed) translation of L-ferritin.
While HHCS is generally associated with childhood 
onset of cataract, there is considerable variation in the appear-
ance and progression of lens opacities (Appendix 2), and many 
patients do not undergo cataract surgery until middle age and 
beyond. Such observations raise the possibility that FTL-IRE 
sequence variations may also contribute to the etiology of 
age-related cataract. Our sequencing data excluded IRE 
variations in a European cohort with clinically well-defined 
Figure 4. Mouse ferritin light 
chain-1 (FTL1) and human ferritin 
light chain (FTL) transcripts are 
expressed in the lens. A: Low 
magnif ication image (sagit tal 
plane) of the mouse eye (postnatal 
day 21) shows strong localization 
of ferritin light chain-1 (FTL1) 
transcripts (red punctate staining) 
to the equatorial epithelium and 
peripheral cortical fiber cells of the 
lens (Co - cornea, CB - ciliary body, 
and iris, Le - lens, Re - retina). B 
and C: High-magnification images 
of FTL1 transcripts expressed in 
the lens anterior epithelium (B) 
and equatorial “bow” region (C). 
Scale bars represent 100 µm. Cell 
nuclei are stained blue. D: Reverse-
transcription polymerase chain 
reaction (RT–PCR) analysis of lens 
RNA detects amplicons containing 
complete coding sequence for FTL and FTL1. Note the FTL1 amplicon (184 codons) is expected to be slightly larger than that of FTL (176 
codons).
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age-related cortical, nuclear, and posterior subcapsular lens 
opacities. A similar study also failed to detect evidence 
for acquired somatic mutations in the FTL-IRE sequence 
of DNA extracted from lens capsular material recovered 
following age-related cataract surgery in an Israeli cohort 
[34]. In contrast, we detected a heterozygous G>A transition 
(c.-346G>A) located 147 nucleotides upstream of the IRE 
that was not listed in the SNP databases in a patient with 
age-related cortical cataract but unknown serum ferritin or 
iron status. Another variation (C>A) located 216 nucleotides 
upstream of the IRE transcription start site has been associ-
ated with elevated levels of FTL mRNA in lymphocytes from 
a cataract patient also of undisclosed serum ferritin and iron 
status [22]. In summary, while FTL-IRE variations clearly 
underlie HHCS, they do not appear to be frequently associ-
ated with age-related cataract in Europeans. Further studies 
will be required to determine the significance of FTL 5′-UTR 
and promoter variations located outside the IRE in the genetic 
etiology of age-related cataract.
APPENDIX 1. GENETIC VARIATION IN THE IRON 
RESPONSE ELEMENT (IRE) AND IMMEDIATE 
FLANKING 5´-UNTRANSLATED REGION (5´-UTR) 
OF THE FERRITIN LIGHT CHAIN (FTL) GENE.
A: Schematic of FTL-IRE sequence (shaded) showing loca-
tion of point-mutations (red), deletions >6bp (bold), deletions 
2–6bp (bold-underline), and 19 variants, listed in dbSNP 
(green). The IRE sequence spans ~75 nucleotides between 
−125c and −199 g, and forms a hairpin-like structure in 
transcribed mRNA with 5′- and 3′- stem regions (gray), a 
hexa-nucleotide loop (yellow), and unpaired 5′-stem regions 
(cyan). The first base, A, of the translation start-site (ATG) is 
numbered +1. The transcription start-site is located at nucleo-
tide −199 g and is numbered 1 in blue. Ex1->=start of exon-1 
at nucleotide −282a. B: Sequence alignment of human (Hs) 
versus mouse (Mm) IRE showing six mismatches (red) in the 
5′- and 3′- stem regions but not in the loop region (yellow). 
To access the data, click or select the words “Appendix 1.”
APPENDIX 2. MUTATION SPECTRUM OF THE 
FERRITIN LIGHT CHAIN-IRON RESPONSE 
ELEMENT (FTL-IRE) SEQUENCE ON 19Q13.4.
To access the data, click or select the words “Appendix 2.”
ACKNOWLEDGMENTS
We thank the family for participating in this study, and 
Belinda McMahan for expert histological assistance. This 
work was supported by NIH/NEI grants RO1EY012284 
(A.S.) and P30EY02687 (Core Grant for Vision Research), an 
unrestricted grant to the Department of Ophthalmology and 
Visual Sciences from Research to Prevent Blindness (RPB), 
and by FIL 2002–2003 (G.M.).
REFERENCES
1. Rahi JS, Dezateux C. Measuring and interpreting the incidence 
of congenital ocular anomalies: lessons from a national study 
of congenital cataract in the UK.  Invest Ophthalmol Vis Sci 
2001; 42:1444-8. [PMID: 11381045].
2. Zetterstrom C, Lundvall A, Kugelberg M. Cataracts in chil-
dren.  J Cataract Refract Surg  2005; 31:824-40. [PMID: 
15899463].
3. Tatham A, Odedra N, Tayebjee S, Anwar S, Woodruff G. The 
incidence of glaucoma following paediatric cataract surgery: 
a 20-year retrospective study.  Eye (Lond)  2010; 24:1366-75. 
[PMID: 20414259].
4. Shiels A, Hejtmancik JF. Genetic origins of cataract.  Arch 
Ophthalmol  2007; 125:165-73. [PMID: 17296892].
5. Hejtmancik JF. Congenital cataracts and their molecular 
genetics  Semin Cell Dev Biol  2008; 19:134-49. [PMID: 
18035564].
6. Shiels A, Bennett TM, Hejtmancik JF. Cat-Map: putting 
cataract on the map.  Mol Vis  2010; 16:2007-15. [PMID: 
21042563].
7. Amaya L, Taylor D, Russelle-Eggitt I, Nischal KK, Lengyel D. 
The morphology and natural history of childhood cataracts. 
Surv Ophthalmol  2003; 48:125-44. [PMID: 12686301].
8. Okano Y, Asada M, Fujimoto A, Ohtake A, Murayama K, 
Hsiao KJ, Choeh K, Yang Y, Cao Q, Reichardt JK, Niihira 
S, Imamura T, Yamano T. A genetic factor for age-related 
cataract: identification and characterization of a novel 
galactokinase variant, “Osaka,” in Asians.  Am J Hum Genet 
2001; 68:1036-42. [PMID: 11231902].
9. Shiels A, Bennett TM, Knopf HL, Maraini G, Li A, Jiao X, 
Hejtmancik JF. The EPHA2 gene is associated with cata-
racts linked to chromosome 1p.  Mol Vis  2008; 14:2042-55. 
[PMID: 19005574].
10. Jun G, Guo H, Klein BE, Klein R, Wang JJ, Mitchell P, Miao 
H, Lee KE, Joshi T, Buck M, Chugha P, Bardenstein D, 
Klein AP, Bailey-Wilson JE, Gong X, Spector TD, Andrew 
T, Hammond CJ, Elston RC, Iyengar SK, Wang B. EPHA2 
is associated with age-related cortical cataract in mice and 
humans.  PLoS Genet  2009; 5:e1000584-[PMID: 19649315].
11. Tan W, Hou S, Jiang Z, Hu Z, Yang P, Ye J. Association of 
EPHA2 polymorphisms and age-related cortical cataract in 
a Han Chinese population.  Mol Vis  2011; 17:1553-8. [PMID: 
21686326].
12. Sundaresan P, Ravindran RD, Vashist P, Shanker A, Nitsch D, 
Talwar B, Maraini G, Camparini M, Nonyane BA, Smeeth 
L, Chakravarthy U, Hejtmancik JF, Fletcher AE. EPHA2 
polymorphisms and age-related cataract in India.  PLoS ONE 
2012; 7:e33001-[PMID: 22412971].
Molecular Vision 2013; 19:835-844 <http://www.molvis.org/molvis/v19/835> © 2013 Molecular Vision 
843
13. Maraini G, Sperduto RD, Ferris F, Clemons TE, Rosmini 
F, Ferrigno L. A randomized, double-masked, placebo-
controlled clinical trial of multivitamin supplementation for 
age-related lens opacities, Clinical trial of nutritional supple-
ments and age-related cataract report no. 3.  Ophthalmology 
2008; 115:599-607. [PMID: 18387406].
14. Maraini G, Hejtmancik JF, Shiels A, Mackay DS, Aldigeri R, 
Jiao XD, Williams SL, Sperduto RD, Reed G. Galactokinase 
gene mutations and age-related cataract, Lack of association 
in an Italian population.  Mol Vis  2003; 9:397-400. [PMID: 
12942049].
15. The age-related eye disease study (AREDS) system for classi-
fying cataracts from photographs: AREDS report no. 4.  Am 
J Ophthalmol  2001; 131:167-75. [PMID: 11228291].
16. Hoffmann K, Lindner TH. easyLINKAGE-Plus–automated 
linkage analyses using large-scale SNP data.  Bioinformatics 
2005; 21:3565-7. [PMID: 16014370].
17. Mackay DS, Andley UP, Shiels A. Cell death triggered by a 
novel mutation in the alphaA-crystallin gene underlies auto-
somal dominant cataract linked to chromosome 21q.  Eur J 
Hum Genet  2003; 11:784-93. [PMID: 14512969].
18. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multi-
locus linkage analysis in humans.  Proc Natl Acad Sci USA 
1984; 81:3443-6. [PMID: 6587361].
19. Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu 
X, Vo HT, Ma XJ, Luo Y. RNAscope: a novel in situ RNA 
analysis platform for formalin-fixed, paraffin-embedded 
tissues.  J Mol Diagn  2012; 14:22-9. [PMID: 22166544].
20. Pras E, Levy-Nissenbaum E, Bakhan T, Lahat H, Assia 
E, Geffen-Carmi N, Frydman M, Goldman B, Pras E. A 
missense mutation in the LIM2 gene is associated with 
autosomal recessive presenile cataract in an inbred Iraqi 
Jewish family.  Am J Hum Genet  2002; 70:1363-7. [PMID: 
11917274].
21. Ponnam SP, Ramesha K, Tejwani S, Matalia J, Kannabiran 
C. A missense mutation in LIM2 causes autosomal reces-
sive congenital cataract.  Mol Vis  2008; 14:1204-8. [PMID: 
18596884].
22. Faniello MC, Di Sanzo M, Quaresima B, Nistico A, Fregola A, 
Grosso M, Cuda G, Costanzo F. Bilateral cataract in a subject 
carrying a C to A transition in the L ferritin promoter region. 
Clin Biochem  2009; 42:911-4. [PMID: 19254706].
23. Lattin JE, Schroder K, Su AI, Walker JR, Zhang J, Wiltshire 
T, Saijo K, Glass CK, Hume DA, Kellie S, Sweet MJ. Expres-
sion analysis of G Protein-Coupled Receptors in mouse 
macrophages.  Immunome Res  2008; 4:5-[PMID: 18442421].
24. Girelli D, Olivieri O, De Franceschi L, Corrocher R, Berga-
maschi G, Cazzola M. A linkage between hereditary hyper-
ferritinaemia not related to iron overload and autosomal 
dominant congenital cataract.  Br J Haematol  1995; 90:931-4. 
[PMID: 7669675].
25. Girelli D, Corrocher R, Bisceglia L, Olivieri O, De Franceschi 
L, Zelante L, Gasparini P. Molecular basis for the recently 
described hereditary hyperferritinemia-cataract syndrome: a 
mutation in the iron-responsive element of ferritin L-subunit 
gene (the “Verona mutation”).  Blood  1995; 86:4050-3. 
[PMID: 7492760].
26. Bonneau D, Winter-Fuseau I, Loiseau MN, Amati P, Berthier 
M, Oriot D, Beaumont C. Bilateral cataract and high serum 
ferritin: a new dominant genetic disorder?  J Med Genet 
1995; 32:778-9. [PMID: 8558554].
27. Beaumont C, Leneuve P, Devaux I, Scoazec JY, Berthier M, 
Loiseau MN, Grandchamp B, Bonneau D. Mutation in the 
iron responsive element of the L ferritin mRNA in a family 
with dominant hyperferritinaemia and cataract.  Nat Genet 
1995; 11:444-6. [PMID: 7493028].
28. Craig JE, Clark JB, McLeod JL, Kirkland MA, Grant G, Elder 
JE, Toohey MG, Kowal L, Savoia HF, Chen C, Roberts S, 
Wirth MG, Mackey DA. Hereditary hyperferritinemia-
cataract syndrome: prevalence, lens morphology, spectrum 
of mutations, and clinical presentations.  Arch Ophthalmol 
2003; 121:1753-61. [PMID: 14662596].
29. Allerson CR, Cazzola M, Rouault TA. Clinical severity and 
thermodynamic effects of iron-responsive element mutations 
in hereditary hyperferritinemia-cataract syndrome  J Biol 
Chem  1999; 274:26439-47. [PMID: 10473603].
30. Ke Y, Theil EC. An mRNA loop/bulge in the ferritin iron-
responsive element forms in vivo and was detected by radical 
probing with Cu-1,10-phenantholine and iron regulatory 
protein footprinting.  J Biol Chem  2002; 277:2373-6. [PMID: 
11714692].
31. Martin ME, Fargion S, Brissot P, Pellat B, Beaumont C. A 
point mutation in the bulge of the iron-responsive element 
of the L ferritin gene in two families with the hereditary 
hyperferritinemia-cataract syndrome.  Blood  1998; 91:319-
23. [PMID: 9414300].
32. Lachlan KL, Temple IK, Mumford AD. Clinical features and 
molecular analysis of seven British kindreds with hereditary 
hyperferritinaemia cataract syndrome.  Eur J Hum Genet 
2004; 12:790-6. [PMID: 15280904].
33. Wong K, Barbin Y, Chakrabarti S, Adams P. A point mutation 
in the iron-responsive element of the L-ferritin in a family 
with hereditary hyperferritinemia cataract syndrome.  Can J 
Gastroenterol  2005; 19:253-5. [PMID: 15861269].
34. Assia N, Goldenberg-Cohen N, Rechavi G, Amariglio N, 
Cohen Y. Mutation analysis of the ferritin L-chain gene in 
age-related cataract.  Mol Vis  2010; 16:2487-93. [PMID: 
21139976].
35. Shekunov J, de Groen PC, Lindor NM, Klee GG, Aleff RA, 
Wieben ED, Mohney BG. Hereditary hyperferritinemia-
cataract syndrome in two large multigenerational American 
families.  J Am Assoc Ped Ophthalmol Strabis  2011; 15:356-
61. [PMID: 21907119].
36. Holzgreve H. Hereditary hyperferritinemia cataract syndrome. 
Dtsch Med Wochenschr  2011; 136:1895-8. [PMID: 21915803].
37. Batey S, Vuillaume I, Devos D, Destee A, Curtis AJ, Lombes 
A, Curtis A, Burn J, Chinnery PF. A novel FTL insertion 
Molecular Vision 2013; 19:835-844 <http://www.molvis.org/molvis/v19/835> © 2013 Molecular Vision 
844
causing neuroferritinopathy.  J Med Genet  2010; 47:71-2. 
[PMID: 20065344].
38. Cremonesi L, Cozzi A, Girelli D, Ferrari F, Fermo I, Foglieni 
B, Levi S, Bozzini C, Camparini M, Ferrari M, Arosio P. 
Case report: a subject with a mutation in the ATG start codon 
of L-ferritin has no haematological or neurological symp-
toms.  J Med Genet  2004; 41:e81-[PMID: 15173247].
39. Kannengiesser C, Jouanolle AM, Hetet G, Mosser A, Muzeau 
F, Henry D, Bardou-Jacquet E, Mornet M, Brissot P, Deugnier 
Y, Grandchamp B, Beaumont C. A new missense mutation 
in the L ferritin coding sequence associated with elevated 
levels of glycosylated ferritin in serum and absence of iron 
overload.  Haematologica  2009; 94:335-9. [PMID: 19176363].
40. Thurlow V, Vadher B, Bomford A, DeLord C, Kannengiesser 
C, Beaumont C, Grandchamp B. Two novel mutations in the 
L ferritin coding sequence associated with benign hyperfer-
rininemia unmasked by glycosylated ferritin assay.  Ann Clin 
Biochem  2012; 49:302-5. [PMID: 22535864].
41. Girelli D, Olivieri O, Gasparini P, Corrocher R. Molecular 
basis for the hereditary hyperferritinemia-cataract syndrome. 
Blood  1996; 87:4912-3. [PMID: 8639868].
42. Brooks DG, Manova-Todorova K, Farmer J, Lobmayr L, 
Wilson RB, Eagle RC Jr, St Pierre TG, Stambolian D. Ferritin 
crystal cataracts in hereditary hyperferritinemia cataract 
syndrome.  Invest Ophthalmol Vis Sci  2002; 43:1121-6. 
[PMID: 11923255].
43. Mumford AD, Cree IA, Arnold JD, Hagan MC, Rixon KC, 
Harding JJ. The lens in hereditary hyperferritinaemia cata-
ract syndrome contains crystalline deposits of L-ferritin.  Br 
J Ophthalmol  2000; 84:697-700. [PMID: 10873976].
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China. 
The print version of this article was created on 11 April 2013. This reflects all typographical corrections and errata to the article 
through that date. Details of any changes may be found in the online version of the article.
